FDA responds to IsoRay's GammaTile 510(k)
The U.S. Food and Drug Administration (FDA) has issued a response to medical...Read more on AuntMinnie.comRelated Reading:
Court approves IsoRay class-action settlement
IsoRay agrees to settle shareholder lawsuit
IsoRay revenue falls, net loss edges up in Q4
IsoRay touts brain brachytherapy study results
IsoRay revenue edges higher, but net loss grows
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Brachytherapy | Brain | Food and Drug Administration (FDA) | Lawsuits | Legislation | Neurology | Study